Navigation Links
Radiation does not improve survival for rare, invasive bladder cancer
Date:6/2/2010

DETROIT In the largest study to date of a rare and deadly form of bladder cancer, researchers at Henry Ford Hospital in Detroit found radiation therapy may not improve a patient's chances for survival.

While overall survival for adenocarcinoma of the bladder was poor, the study revealed several factors that may improve a patient's prognosis, including being diagnosed at age 60 or younger, and having cystectomy, a procedure that either removes all or a portion of the bladder.

"While this malignancy afflicts just one to two percent of people diagnosed with bladder cancer, chances of surviving it for five years are grim only 18 percent in part because it is usually detected at an advanced stage," says study lead author Naveen Pokala, M.D., an urologist at Henry Ford Hospital.

"By the time the primary cancer is found, it may already have penetrated all four walls of the bladder and spread to adjacent organs and beyond, including the peritoneum, lymph nodes, and lungs."

The study will be presented June 2 at the 2010 American Urology Association's annual meeting in San Francisco.

In 2009, the National Cancer Institute estimated 70,980 new cases of bladder cancer were diagnosed in the U.S., while 14,330 died of the disease. According to the American Cancer Society, only about 1 percent of bladder cancers are adenocarcinomas. It invades the mucous cells in the bladder lining, and is the result of chronic irritation and inflammation. Nearly all adenocarcinomas of the bladder are invasive.

For their study, researchers at Henry Ford Hospital studied more than 850 patients with adenocarcinoma of the bladder, all selected from the National SEER database.

Of the study group, 96 patients had had a partial cystectomy; 164 had a total cystectomy; 375 had an endoscopy procedure; and 202 had an unspecified surgery. Among this group, some patients were treated with radiation therapy.

The population-based study had a mean age of 66.9 years among 514 males and 338 women; 707 were white, 94 African American, and 51 other races.

Race, the year of diagnosis, and radiation therapy did not affect survival.

Their overall survival rate was poor. The factors found in better prognoses were age 60 or younger; a well-differentiated, localized tumor in the dome (top) of the bladder, or the urachus, a vestigial cord that once connected the fetal bladder and contributed to development of the umbilical cord; and a total or partial cystectomy.


'/>"/>

Contact: Krista Hopson
khopson1@hfhs.org
313-874-7207
Henry Ford Health System
Source:Eurekalert

Related medicine news :

1. Radiation for Prostate Cancer May Boost Fracture Risk
2. Radiation Not Needed in Many Older Breast Cancer Patients
3. John Theurer Cancer Center offers breakthrough radiation measurement technology
4. Motorcycle Cancer Risk and ELF EMF Radiation Invasion of Gastrointestinal Melatonin
5. Concerns over radiation exposure may overshadow life-saving benefits of cardiac imaging tests
6. Simple reduction technique decreases radiation dose associated with CT scans of the head
7. Radiation Risks Nearly Double for Younger CT Scan Patients
8. Novel nanoparticles prevent radiation damage
9. Researchers successfully lower radiation dose associated with pediatric chest CT scans
10. Terminal cancer patients do not receive appropriate radiation therapy
11. Too Much Radiation? The FDA Wants to Know
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... ... communities throughout the greater Cincinnati metropolitan area, is teaming up with the local ... families with children receiving treatment in nearby hospitals. , Ronald McDonald House of ...
(Date:6/27/2017)... ... 2017 , ... Harbour , a DAO (decentralized autonomous organization) that harnesses ... released their technical specifications . , 2017 has seen an explosion of token ... determining which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of ...
(Date:6/27/2017)... , ... June 27, 2017 , ... From June 20-22, ... three-day event was held in Syracuse, New York, where EarQ is headquartered. , ... how to connect with today’s savvy consumer, and the latest in hearing technology. ...
(Date:6/27/2017)... New York, NY (PRWEB) , ... June 27, ... ... communications and marketing experts to contribute to an upcoming case studies guidebook. This ... or her organization. , This book will include articles, case studies and how-to’s ...
(Date:6/27/2017)... ... ... Hammer Strength, the world’s leading performance strength training brand, and the National ... the NBSCA Strength & Conditioning Coach of the Year. , In its 11th ... select the coach who embodies the highest level of excellence and outstanding service to ...
Breaking Medicine News(10 mins):
(Date:6/1/2017)... BLUE BELL, Pa. , June 1, 2017 /PRNewswire/ ... Nutriceuticals (PRN) and Veterinarian Recommended Solutions (VRS), and KD ... direct investment in Nutriceutical Holdings by KD Pharma Group. ... Nutriceutical Holdings with the option to acquire the entire ... ideal partner in KD. They are committed to growing ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
(Date:5/26/2017)... , May 25, 2017  In response to the ... , Direct Relief is working with Pfizer to make ... at no cost to community health centers, free and ... nationwide. "Pfizer has a long-standing commitment ... and ensuring patient safety through educational activities," said ...
Breaking Medicine Technology: